bezafibrate has been researched along with Hypertension in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM | 1 |
| Dushkin, MI; Khrapova, MV; Mel'nikova, EV; Panteleeva, NG; Shurlygina, AV; Tenditnik, MI; Trufakin, VA | 1 |
| Hayashi, S; Iwashima, Y; Kawano, Y; Nakamura, S; Ohta, Y; Yoshihara, F | 1 |
| Kotake, H | 1 |
| Fujioka, Y; Iwasaki, T; Masai, M; Morimoto, S; Ohyanagi, M; Okumura, T; Tsuboi, S; Tsujino, T | 1 |
| Fujioka, Y; Kim, JI; Saito, K; Tsujino, T; Yokoyama, M | 1 |
| Malcolm, J; Meggison, H; Sigal, R | 1 |
| Oron-Herman, M; Rosenthal, T; Sela, BA | 1 |
| Arnaout, A; Malcolm, J; Sigal, R | 1 |
| Pöch, G | 1 |
| Barasch, E; Behar, S; Benderly, M; Caspi, A; Goldbourt, U; Graff, E; Pelled, B; Reicher-Reiss, H; Reisin, L; Roguin, N | 1 |
| Fukamachi, I; Hashimoto, H; Kobayashi, J; Niihara, K; Saito, Y; Sasaki, N; Shirai, K; Takahashi, K; Tashiro, J; Yoshida, S | 1 |
| Ariad, S; Hechtlinger, V | 1 |
| Beggs, PW; Clark, DW; Coulter, DM; Williams, SM | 1 |
| Gross, V; Luft, FC; Mervaala, E; Schneider, W; Schunck, WH | 1 |
| Richey, JM; Si, X; Webb, RC | 1 |
| Erdmann, B; Gross, V; Honeck, H; Kärgel, E; Luft, FC; Milia, AF; Neunaber, R; Schneider, W; Schunck, WH | 1 |
| Grassi, G; Taddei, S | 1 |
| Hattori, A; Iguchi, A; Kuzuya, M; Muraguchi, M; Nakamura, J; Ohmoto, Y; Tamaya, N; Ueda, M; Uemura, K; Yoshioka, S | 1 |
| Autonell, J; Brugués, J; Kanterewicz, E; Riba, J; Sanmartí, R; Trias, I | 1 |
| Green, KG; Heady, A; Oliver, MF | 1 |
6 review(s) available for bezafibrate and Hypertension
| Article | Year |
|---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2000 |
[Syndrome X].
Topics: Animals; Bezafibrate; Biguanides; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Leptin; Life Style; Metabolic Syndrome; Pioglitazone; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2002 |
Prevention of cardiovascular events in diabetes.
Topics: Angioplasty, Balloon; Antihypertensive Agents; Aspirin; Bezafibrate; Cardiovascular Diseases; Coronary Artery Bypass; Diabetic Angiopathies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Platelet Glycoprotein GPIIb-IIIa Complex; Smoking Cessation | 2004 |
Prevention of cardiovascular events in diabetes.
Topics: Angioplasty, Balloon; Antihypertensive Agents; Aspirin; Bezafibrate; Cardiovascular Diseases; Clopidogrel; Diabetic Angiopathies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Smoking Cessation; Ticlopidine | 2006 |
Antihypertensive mechanisms of lipid-lowering drugs: decoding the Rosetta stone's inscriptions'.
Topics: Antihypertensive Agents; Bezafibrate; Humans; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents | 2001 |
Bezafibrate induced rhabdomyolysis.
Topics: Aged; Bezafibrate; Female; Humans; Hypercholesterolemia; Hypertension; Indomethacin; Rhabdomyolysis | 1992 |
3 trial(s) available for bezafibrate and Hypertension
| Article | Year |
|---|---|
Effect of bezafibrate on office, home and ambulatory blood pressure in hypertensive patients with dyslipidemia.
Topics: Aged; Antihypertensive Agents; Bezafibrate; Biomarkers; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Dyslipidemias; Female; Humans; Hypertension; Hypolipidemic Agents; Insulin; Insulin Resistance; Japan; Lipids; Male; Middle Aged; Office Visits; Predictive Value of Tests; Treatment Outcome | 2013 |
Bezafibrate improves hypertension and insulin sensitivity in humans.
Topics: Adult; Apolipoproteins; Bezafibrate; Blood Glucose; Blood Pressure; Body Mass Index; Cell Membrane; Erythrocyte Membrane; Fatty Acids; Heart Rate; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Insulin; Insulin Resistance; Lipids; Male | 2003 |
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study.
Topics: Age Factors; Aged; Bezafibrate; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Israel; Male; Middle Aged; Motor Activity; Multivariate Analysis; Myocardial Infarction; Risk Factors; Sex Factors; Smoking; Triglycerides | 1995 |
12 other study(ies) available for bezafibrate and Hypertension
| Article | Year |
|---|---|
Bezafibrate causes depression of the immune response and increases the sensitivity to endotoxin in association with low level of HDL and PPARα activity in hypertensive ISIAH rats.
Topics: Adaptive Immunity; Animals; Bezafibrate; Cholesterol, HDL; Hypertension; Hypolipidemic Agents; Immunosuppressive Agents; Lipopolysaccharides; Liver; Lymphocyte Count; PPAR alpha; Rats; Rats, Wistar; Spleen; Thymus Gland | 2013 |
Troglitazone reduces activity of the Na+/H+ exchanger in fructose-fed borderline hypertensive rats.
Topics: Animals; Bezafibrate; Blood Glucose; Blood Platelets; Blood Pressure; Calcium; Chromans; Diet; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Fructose; Hydrogen-Ion Concentration; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Male; Propionates; Rats; Sodium-Hydrogen Exchangers; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone; Vasodilator Agents | 2003 |
Risk reduction therapy for syndrome X: comparison of several treatments.
Topics: Amlodipine; Animals; Antihypertensive Agents; Bezafibrate; Blood Pressure; Body Weight; Captopril; Fructose; Hydrolases; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones; Triglycerides | 2005 |
[Initial values and drug effects].
Topics: Asthma; Bezafibrate; Blood Pressure Determination; Chlorthalidone; Cholesterol; Clenbuterol; Humans; Hypercholesterolemia; Hypertension; Indapamide; Placebos; Regression Analysis | 1984 |
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Topics: Adult; Aged; Bezafibrate; Blood Glucose; Female; Glucose Intolerance; Humans; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Immunoenzyme Techniques; Insulin; Lipase; Lipoprotein Lipase; Liver; Male; Middle Aged; Triglycerides | 1994 |
Bezafibrate-induced neutropenia.
Topics: Bezafibrate; Dyspnea; Female; Flushing; Humans; Hyperlipidemias; Hypertension; Leukocyte Count; Middle Aged; Neutropenia; Nifedipine; Urticaria | 1993 |
A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP).
Topics: Bezafibrate; Cohort Studies; Comorbidity; Diabetes Complications; Female; Gemfibrozil; Humans; Hypertension; Lipids; Male; Myocardial Ischemia; New Zealand; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; Random Allocation; Retrospective Studies; Risk Factors; Simvastatin; Surveys and Questionnaires; Treatment Outcome | 1999 |
Chronic effects of lovastatin and bezafibrate on cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice.
Topics: Animals; Anticholesteremic Agents; Bezafibrate; Blood Flow Velocity; Desoxycorticosterone; Diuresis; Hypertension; Hypolipidemic Agents; Kidney Cortex; Kidney Medulla; Lovastatin; Mice; Pressure; Renal Circulation; Vascular Resistance | 1999 |
Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Bezafibrate; Blood Pressure; Body Weight; Calcium Channel Agonists; Dose-Response Relationship, Drug; Fructose; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; In Vitro Techniques; Lipoproteins, VLDL; Male; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1999 |
Cytochrome P450-dependent renal arachidonic acid metabolism in desoxycorticosterone acetate-salt hypertensive mice.
Topics: Animals; Arachidonic Acid; Bezafibrate; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Desoxycorticosterone; Hydroxyeicosatetraenoic Acids; Hydroxylation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; In Situ Hybridization; Kidney; Lovastatin; Male; Mice; Mice, Inbred Strains; Microsomes; Mixed Function Oxygenases; NADP; Nephrectomy; RNA, Messenger; Sodium Chloride | 2000 |
Noninvolvement of hypertriglyceridemia and hyperleptinemia in blood pressure increases induced by dietary lard in rats.
Topics: Adipose Tissue; Animals; Bezafibrate; Blood Glucose; Blood Pressure; Cholesterol; Diet; Dietary Fats; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Leptin; Male; Rats; Rats, Wistar; Safflower Oil | 2001 |
Blood pressure, cigarette smoking and heart attack in the WHO co-operative trial of clofibrate.
Topics: Bezafibrate; Clofibrate; Coronary Disease; Fibrinogen; Humans; Hypertension; Male; Smoking; World Health Organization | 1989 |